Literature DB >> 17992658

Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome.

Lone Holst1, Hedvig Nordeng, Svein Haavik.   

Abstract

PURPOSE: To study characteristics of women using herbal drugs and the possible impact of use in early pregnancy on pregnancy outcome.
METHODS: Data on the use of herbal drugs during pregnancy were obtained from the Swedish Medical Birth Register during the period 1st July 1995 to end of 2004. Women who reported use of herbal drugs were compared to all women giving birth during the period. Outcome variables were prematurity, birth weight, Apgar score, number of infants in delivery and congenital malformations.
RESULTS: Among the 860 215 women in the register, 787 (0.9%) reported use of herbal drugs during early pregnancy. The most frequently used herbal drugs were Floradix (iron-rich herbs), ginseng and valerian. Use of such drugs was independently associated with high maternal age, normal weight and 14-15 years of education. Risk factors for valerian differed from those for other herbal drugs, for example with respect to maternal smoking and country of birth. Concomitant drug use was common and the most frequently used drugs were multivitamins, folic acid, cardiovascular drugs (mainly antihypertensive drugs), non-steroid anti-inflammatory drugs (NSAIDs), analgesics and psycholeptics. None of the infant characteristics studied were influenced significantly by the mother's use of the examined herbal drugs during early pregnancy.
CONCLUSIONS: The most commonly reported herbal drugs used during pregnancy were Floradix (iron-rich herbs), ginseng and valerian. No signs of unfavourable effect on pregnancy outcome were seen. The number of exposures, however, was low and therefore effects on rare outcomes (e.g. specific malformations) cannot be excluded. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17992658     DOI: 10.1002/pds.1527

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  20 in total

1.  Use of herbal treatments in pregnancy.

Authors:  Carol Louik; Paula Gardiner; Katherine Kelley; Allen A Mitchell
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

Review 2.  Herbal Medicines Use During Pregnancy: A Review from the Middle East.

Authors:  Lisha J John; Nisha Shantakumari
Journal:  Oman Med J       Date:  2015-07

3.  Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study.

Authors:  K Heitmann; G C Havnen; L Holst; H Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2016-02-19       Impact factor: 2.953

4.  Foetal exposure to Panax ginseng extract reverts the effects of prenatal dexamethasone in the synthesis of testosterone by Leydig cells of the adult rat.

Authors:  Maria I Wanderley; Karina L A Saraiva; Juliany S B César Vieira; Christina A Peixoto; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2013-06       Impact factor: 1.925

Review 5.  Review of cases of patient risk associated with ginseng abuse and misuse.

Authors:  Doo Jin Paik; Chang Ho Lee
Journal:  J Ginseng Res       Date:  2014-12-06       Impact factor: 6.060

6.  Complementary and alternative medicine use in pregnancy in Mashhad, Iran, 2007-8.

Authors:  Talat Khadivzadeh; Mahboobeh Ghabel
Journal:  Iran J Nurs Midwifery Res       Date:  2012-05

7.  A survey describing the use of complementary therapies and medicines by women attending a family planning clinic.

Authors:  Caroline A Smith; Deborah J Bateson; Edith Weisberg
Journal:  BMC Complement Altern Med       Date:  2013-09-11       Impact factor: 3.659

8.  Herbal medicine use in pregnancy: results of a multinational study.

Authors:  Deborah A Kennedy; Angela Lupattelli; Gideon Koren; Hedvig Nordeng
Journal:  BMC Complement Altern Med       Date:  2013-12-12       Impact factor: 3.659

9.  Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey.

Authors:  James S McLay; Naila Izzati; Abdul R Pallivalapila; Ashalatha Shetty; Binita Pande; Craig Rore; Moza Al Hail; Derek Stewart
Journal:  BMC Complement Altern Med       Date:  2017-12-19       Impact factor: 3.659

10.  Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany.

Authors:  Francesco Lapi; Alfredo Vannacci; Martina Moschini; Fabrizio Cipollini; Maria Morsuillo; Eugenia Gallo; Grazia Banchelli; Enrica Cecchi; Marina Di Pirro; Maria Grazia Giovannini; Maria Teresa Cariglia; Luigi Gori; Fabio Firenzuoli; Alessandro Mugelli
Journal:  Evid Based Complement Alternat Med       Date:  2008-05-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.